ERBB2 and urinary bladder cancer: Genes co-amplified with ERBB2 (GRB7, MIEN1, PGAP3, and STARD3) exhibited the highest amplification frequency in esophageal cancer, followed by stomach, breast, uterine, and bladder cancer (Figure 8B).